To learn more about a specific study, click on the study name from the menu bar on the left or the study name below!
| Study | Aim and Eligibility |
| Pre-Prom | Aim: Compare the safety and effectiveness of subpectoral vs. prepectoral breast reconstruction Eligible: – Are a woman, aged 18 or over – Undergoing total mastectomy (surgery to remove the breast), for breast cancer or risk reduction, with immediate breast reconstruction using a tissue expander or implant (alloplastic breast reconstruction) – Are fluent in English |
| Flap-Prom | Aim: Understand the restoration of sensation using neurotization and non-neurotization in autologous breast reconstruction Eligible: – Are female, aged 19 or over – Are undergoing total mastectomy (surgery to remove the breast), for breast cancer or risk reduction, with immediate breast reconstruction using your own tissue (autologous breast reconstruction) with or without axillary surgery |
| ADM | Aim: Compare four different acellular dermal matrices used in breast reconstruction Eligible: – All woman aged 21 years or older but less than 65 undergoing mastectomy and breast reconstruction with a tissue expander and ADM will be invited to participate. |
| Lymphedema QoL | Aim: Examine the Quality of Life in the lymphedema population before and after surgical intervention Eligible: – 18 years or older – Have lymphedema – Eligible for surgical intervention |
| Lymph Trial | Aim: Test whether lymphatic surgery provides better quality of life (QoL) compared to complex physical decongestion therapy (CDT) for patients with breast cancer-related lymphedema (BCRL). Eligible: – Patients ≥ 18 years of age with prior treatment of breast cancer. – At least one of the following prior breast cancer treatments: Sentinel lymph node biopsy (SLNB), axillary lymph node dissection (ALND), radiotherapy (RT) of chest wall or axilla or breast cancer surgery. – Clinical diagnosis of chronic BCRL as defined by the international society of lymphology (ISL; inter-limb difference of >10% in volume or excess volume between the affected and non-affected arm present for more than 3 months). – Minimum of 3 months CDT. – Ability to complete the QoL questionnaires. |